162 related articles for article (PubMed ID: 36169236)
1. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
[No Abstract] [Full Text] [Related]
2. A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy.
Liu M; Zhao X; Pan W; Qian Z; Du M; Wang LM; Huang H; Xiao H
Br J Haematol; 2021 Oct; 195(2):e123-e128. PubMed ID: 34254314
[No Abstract] [Full Text] [Related]
3. Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.
Xu J; Li H; Wang Z; Wang M; Li Q; Hang X; Xu J; Ji J; Chen C; Liu Y; Niu T
Mol Carcinog; 2024 Apr; 63(4):553-557. PubMed ID: 38131515
[TBL] [Abstract][Full Text] [Related]
4. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
5. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA.
Morimoto S; Kondo T; Taya T; Matsuo H; Teramoto Y; Mizumoto C; Kanda J; Yamashita K; Takaori-Kondo A
Ann Hematol; 2022 May; 101(5):1129-1132. PubMed ID: 35347397
[No Abstract] [Full Text] [Related]
6. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
Lechevalier N; Dulucq S; Bidet A
Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
[No Abstract] [Full Text] [Related]
7. Variant
Dowse RT; Ireland RM
Blood; 2017 Apr; 129(14):2038. PubMed ID: 28385775
[No Abstract] [Full Text] [Related]
8. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
Pardo Gambarte L; Franganillo Suárez A; Cornago Navascués J; Soto de Ozaeta C; Blas López C; Atance Pasarisas M; Salgado Sánchez RN; Serrano Del Castillo C; Mata Serna R; Velasco Rodríguez D; López-Lorenzo JL; Llamas-Sillero P; Solán Blanco L
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454359
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.
Chen Y; Pan M; Chen L; Peng M; Liu Z; Fang Y; Du Y; Yang Y; Xu P
Ann Hematol; 2024 Apr; 103(4):1181-1185. PubMed ID: 38294534
[TBL] [Abstract][Full Text] [Related]
10. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
11. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
[No Abstract] [Full Text] [Related]
12. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
13. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.
Adams J; Nassiri M
Arch Pathol Lab Med; 2015 Oct; 139(10):1308-13. PubMed ID: 26414475
[TBL] [Abstract][Full Text] [Related]
14. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Yang X; Zhang R; Zhang Z
Ann Hematol; 2022 Sep; 101(9):2101-2102. PubMed ID: 35704083
[No Abstract] [Full Text] [Related]
15. Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report.
Li Y; Yu J; Xu Q; Zhang K
Medicine (Baltimore); 2021 Dec; 100(48):e28076. PubMed ID: 35049232
[TBL] [Abstract][Full Text] [Related]
16. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
[No Abstract] [Full Text] [Related]
17. Venetoclax for arsenic-resistant acute promyelocytic leukaemia.
Wang QQ; Wang HF; Zhao JZ; Naranmandura H; Jin J; Zhu HH
Br J Haematol; 2022 Jun; 197(5):e58-e60. PubMed ID: 35176809
[No Abstract] [Full Text] [Related]
18. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
[TBL] [Abstract][Full Text] [Related]
19. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
20. FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
Cheng CK; Wang AZ; Wong THY; Wan TSK; Cheung JS; Raghupathy R; Chan NPH; Ng MHL
Blood; 2017 May; 129(19):2705-2709. PubMed ID: 28314734
[No Abstract] [Full Text] [Related]
[Next] [New Search]